-+ 0.00%
-+ 0.00%
-+ 0.00%

Lilly's Inluriyo Shows Strong Efficacy in Advanced ER+ Breast Cancer in Phase 3 Study

路透·12/12/2025 16:45:24

登錄查看新聞詳情